title: Lack of unwanted effects of oseltamivir carboxylate in juvenile rats after subcutaneous administration.
authors.affiliation: Non-Clinical Safety, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland. christian.freichel@roche.com
authors.forename: Christian
authors.initials: C
authors.lastname: Freichel
authors.forename: Alexander
authors.initials: A
authors.lastname: Breidenbach
authors.forename: Laurent
authors.initials: L
authors.lastname: Gand
authors.forename: Jonathan
authors.initials: J
authors.lastname: Toot
authors.forename: Thomas
authors.initials: T
authors.lastname: Weiser
authors.forename: Annette
authors.initials: A
authors.lastname: Körner
authors.forename: Thomas
authors.initials: T
authors.lastname: Singer
authors.forename: Eric
authors.initials: E
authors.lastname: Prinssen
authors.forename: Gerhard
authors.initials: G
authors.lastname: Hoffmann
mesh_terms: D000367:Age Factors; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics; D019540:Area Under Curve; D005260:Female; D007279:Injections, Subcutaneous; D008297:Male; D053139:Oseltamivir / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D012737:Sex Factors
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir; C535162:oseltamivir carboxylate